| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |